A detailed history of Aveo Capital Partners, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Aveo Capital Partners, LLC holds 9,042 shares of JNJ stock, worth $1.42 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
9,042
Previous 9,396 3.77%
Holding current value
$1.42 Million
Previous $1.49 Million 11.1%
% of portfolio
0.16%
Previous 0.17%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$144.38 - $157.78 $51,110 - $55,854
-354 Reduced 3.77%
9,042 $1.32 Million
Q1 2024

May 06, 2024

BUY
$155.22 - $162.74 $298,953 - $313,437
1,926 Added 25.78%
9,396 $1.49 Million
Q4 2023

Feb 06, 2024

SELL
$145.6 - $158.88 $65,083 - $71,019
-447 Reduced 5.65%
7,470 $1.17 Million
Q3 2023

Nov 06, 2023

BUY
$155.75 - $174.48 $4,516 - $5,059
29 Added 0.37%
7,917 $1.23 Million
Q1 2023

May 03, 2023

SELL
$151.05 - $180.26 $697,699 - $832,620
-4,619 Reduced 36.93%
7,888 $1.22 Million
Q4 2022

Feb 03, 2023

SELL
$160.2 - $179.79 $218,032 - $244,694
-1,361 Reduced 9.81%
12,507 $2.21 Million
Q3 2022

Nov 09, 2022

SELL
$161.33 - $179.52 $332,985 - $370,529
-2,064 Reduced 12.96%
13,868 $2.27 Million
Q2 2022

Aug 05, 2022

SELL
$168.19 - $186.01 $299,210 - $330,911
-1,779 Reduced 10.04%
15,932 $2.83 Million
Q1 2022

May 13, 2022

SELL
$158.14 - $179.59 $1.32 Million - $1.5 Million
-8,348 Reduced 32.03%
17,711 $3.14 Million
Q4 2021

Feb 11, 2022

BUY
$155.93 - $173.01 $3.13 Million - $3.47 Million
20,077 Added 335.62%
26,059 $4.46 Million
Q3 2021

Nov 12, 2021

BUY
$161.5 - $179.47 $109,174 - $121,321
676 Added 12.74%
5,982 $966,000
Q2 2021

Aug 13, 2021

BUY
$159.48 - $171.07 $6,379 - $6,842
40 Added 0.76%
5,306 $874,000
Q1 2021

May 11, 2021

BUY
$153.07 - $170.48 $546,766 - $608,954
3,572 Added 210.86%
5,266 $866,000
Q4 2020

Feb 10, 2021

SELL
$137.11 - $157.38 $257,492 - $295,559
-1,878 Reduced 52.58%
1,694 $267,000
Q3 2020

Nov 13, 2020

BUY
$140.38 - $153.83 $501,437 - $549,480
3,572 New
3,572 $532,000
Q2 2020

Aug 12, 2020

SELL
$128.81 - $155.51 $455,729 - $550,194
-3,538 Closed
0 $0
Q1 2020

May 05, 2020

SELL
$111.14 - $153.99 $38,454 - $53,280
-346 Reduced 8.91%
3,538 $464,000
Q4 2019

Feb 06, 2020

SELL
$127.5 - $146.44 $15,555 - $17,865
-122 Reduced 3.05%
3,884 $567,000
Q3 2019

Nov 07, 2019

BUY
$126.95 - $142.14 $11,044 - $12,366
87 Added 2.22%
4,006 $522,000
Q2 2019

Aug 06, 2019

BUY
$131.15 - $144.24 $6,295 - $6,923
48 Added 1.24%
3,919 $509,000
Q1 2019

May 07, 2019

BUY
$125.72 - $139.79 $11,566 - $12,860
92 Added 2.43%
3,871 $541,000
Q4 2018

Feb 11, 2019

SELL
$122.84 - $147.84 $31,569 - $37,994
-257 Reduced 6.37%
3,779 $488,000
Q3 2018

Nov 09, 2018

SELL
$121.58 - $142.88 $240,120 - $282,188
-1,975 Reduced 32.86%
4,036 $560,000
Q2 2018

Aug 14, 2018

SELL
$119.4 - $131.76 $53,252 - $58,764
-446 Reduced 6.91%
6,011 $729,000
Q1 2018

May 11, 2018

BUY
$125.1 - $148.14 $96,076 - $113,771
768 Added 13.5%
6,457 $827,000
Q4 2017

Feb 05, 2018

BUY
$131.22 - $143.62 $73,614 - $80,570
561 Added 10.94%
5,689 $795,000
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $663,922 - $694,228
5,128
5,128 $667,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $410B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Aveo Capital Partners, LLC Portfolio

Follow Aveo Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aveo Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aveo Capital Partners, LLC with notifications on news.